Heinzl, M.W.; Kolenchery, L.; Resl, M.; Klammer, C.; Black, A.; Obendorf, F.; Schinagl, L.; Feldbauer, R.; Pohlhammer, J.; Wagner, T.;
et al. High Anti-CoV2S Antibody Levels at Hospitalization Are Associated with Improved Survival in Patients with COVID-19 Vaccine Breakthrough Infection. Int. J. Environ. Res. Public Health 2022, 19, 15581.
https://doi.org/10.3390/ijerph192315581
AMA Style
Heinzl MW, Kolenchery L, Resl M, Klammer C, Black A, Obendorf F, Schinagl L, Feldbauer R, Pohlhammer J, Wagner T,
et al. High Anti-CoV2S Antibody Levels at Hospitalization Are Associated with Improved Survival in Patients with COVID-19 Vaccine Breakthrough Infection. International Journal of Environmental Research and Public Health. 2022; 19(23):15581.
https://doi.org/10.3390/ijerph192315581
Chicago/Turabian Style
Heinzl, Matthias Wolfgang, Lisa Kolenchery, Michael Resl, Carmen Klammer, Anne Black, Florian Obendorf, Lukas Schinagl, Roland Feldbauer, Johannes Pohlhammer, Thomas Wagner,
and et al. 2022. "High Anti-CoV2S Antibody Levels at Hospitalization Are Associated with Improved Survival in Patients with COVID-19 Vaccine Breakthrough Infection" International Journal of Environmental Research and Public Health 19, no. 23: 15581.
https://doi.org/10.3390/ijerph192315581
APA Style
Heinzl, M. W., Kolenchery, L., Resl, M., Klammer, C., Black, A., Obendorf, F., Schinagl, L., Feldbauer, R., Pohlhammer, J., Wagner, T., Berger, T., Dieplinger, B., & Clodi, M.
(2022). High Anti-CoV2S Antibody Levels at Hospitalization Are Associated with Improved Survival in Patients with COVID-19 Vaccine Breakthrough Infection. International Journal of Environmental Research and Public Health, 19(23), 15581.
https://doi.org/10.3390/ijerph192315581
